Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
McKinsey
Boehringer Ingelheim
Express Scripts
Dow

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Patent: 6,372,962

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 6,372,962
Title: Pathogen resistance in plants using CDNA-N/intron constructs
Abstract:Constructs comprising (1) a cDNA molecule corresponding to the tobacco N gene and (2) at least a portion of the third intron of the N gene are disclosed. Such constructs are useful for producing TMV resistance in plants.
Inventor(s): Baker; Barbara J. (Richmond, CA), Dinesh-Kumar; S. P. (New Haven, CT)
Assignee: The Regents of the University of California (Oakland, CA) The United States of America as represented by the Secretary of Agriculture (Washington, DC)
Application Number:09/357,206
Patent Claims:see list of patent claims

Details for Patent 6,372,962

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial The Regents of the University of California (Oakland, CA) The United States of America as represented by the Secretary of Agriculture (Washington, DC) 2018-07-20 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial The Regents of the University of California (Oakland, CA) The United States of America as represented by the Secretary of Agriculture (Washington, DC) 2018-07-20 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial The Regents of the University of California (Oakland, CA) The United States of America as represented by the Secretary of Agriculture (Washington, DC) 2018-07-20 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Mallinckrodt
Boehringer Ingelheim
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.